Nianrong A. Mi
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight (LIGHT 1): A randomized, double-blind, placebo-controlled, ascending-dose phase 2a trial.
Journal: Diabetes, obesity & metabolism
Published: September 30, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial.
Journal: The lancet. Diabetes & endocrinology
Published: March 30, 2025
Identification of potential immunotherapeutic targets and prognostic biomarkers in Graves' disease using weighted gene co-expression network analysis.
Journal: Heliyon
Published: July 21, 2023
Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment.
Journal: Clinical pharmacokinetics
Published: April 20, 2023
Diabetes remission in drug-naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study.
Journal: Diabetes, obesity & metabolism
Published: March 28, 2023
Evaluation of the effects of vitamin D deficiency and cigarette smoking on insulin resistance in type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: January 23, 2023
Bioinformatic analysis of specific genes in diabetic nephropathy.
Journal: Renal failure
Published: July 10, 2015
Effects of basal insulin application on serum visfatin and adiponectin levels in type 2 diabetes.
Journal: Experimental and therapeutic medicine
Published: March 17, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026